Tocilizumab (Actemra) for giant cell arteritis

Carl W. Bazil, Ericka L. Crouse, Vanessa K. Dalton, Eric J. Epstein, David N. Juurlink, Richard B. Kim, Franco M. Muggia, Sandip K. Mukherjee, Dan M. Roden, Esperance A.K. Schaefer, F. Estelle R. Simons, Neal H. Steigbigel, Arthur M.F. Yee

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)161-162
Number of pages2
JournalMedical Letter on Drugs and Therapeutics
Issue number1530
StatePublished - Sep 25 2017

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Bazil, C. W., Crouse, E. L., Dalton, V. K., Epstein, E. J., Juurlink, D. N., Kim, R. B., Muggia, F. M., Mukherjee, S. K., Roden, D. M., Schaefer, E. A. K., Simons, F. E. R., Steigbigel, N. H., & Yee, A. M. F. (2017). Tocilizumab (Actemra) for giant cell arteritis. Medical Letter on Drugs and Therapeutics, 59(1530), 161-162.